Funding for this research was provided by:
Medistim A/S (N/A)
Text and Data Mining valid from 2019-03-13
Received: 12 December 2018
Accepted: 4 March 2019
First Online: 13 March 2019
Ethics approval and consent to participate
: Use of the echoclip stabilizing device and use of coagulated blood from the patient was approved by the Ethics committee of the Nord Denmark Region (N-20160012) and by the Danish Medicines Agency (reference number 2016020479), and the patient gave his informed written consent to participate in a clinical study (ClinicalTrials.gov ID: NCT02919124; Registered September 29, 2016).
: The patient gave written consent to anonymous publication of the data.
: The corresponding author is a co-inventor of the echoclip device, and the North Denmark Region holds a patent of the echoclip device.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.